MD20150017A2 - Use of Polybiolin drug in patients with liver cirrhosis - Google Patents

Use of Polybiolin drug in patients with liver cirrhosis

Info

Publication number
MD20150017A2
MD20150017A2 MDA20150017A MD20150017A MD20150017A2 MD 20150017 A2 MD20150017 A2 MD 20150017A2 MD A20150017 A MDA20150017 A MD A20150017A MD 20150017 A MD20150017 A MD 20150017A MD 20150017 A2 MD20150017 A2 MD 20150017A2
Authority
MD
Moldova
Prior art keywords
drug
polybiolin
patients
liver cirrhosis
medicine
Prior art date
Application number
MDA20150017A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD4458C1 (en
MD4458B1 (en
Inventor
Maria Danu
Galina Pavliuc
Original Assignee
Maria Danu
Galina Pavliuc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maria Danu, Galina Pavliuc filed Critical Maria Danu
Priority to MDA20150017A priority Critical patent/MD4458C1/en
Publication of MD20150017A2 publication Critical patent/MD20150017A2/en
Publication of MD4458B1 publication Critical patent/MD4458B1/en
Publication of MD4458C1 publication Critical patent/MD4458C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to medicine, namely to the use of Polybiolin drug in patients with liver cirrhosis, wherein the drug is administered intramuscularly, 5 ml for 8…10 days.
MDA20150017A 2014-06-19 2014-06-19 Use of Polybiolin drug in patients with liver cirrhosis MD4458C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20150017A MD4458C1 (en) 2014-06-19 2014-06-19 Use of Polybiolin drug in patients with liver cirrhosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20150017A MD4458C1 (en) 2014-06-19 2014-06-19 Use of Polybiolin drug in patients with liver cirrhosis

Publications (3)

Publication Number Publication Date
MD20150017A2 true MD20150017A2 (en) 2016-04-30
MD4458B1 MD4458B1 (en) 2017-01-31
MD4458C1 MD4458C1 (en) 2017-08-31

Family

ID=55911138

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20150017A MD4458C1 (en) 2014-06-19 2014-06-19 Use of Polybiolin drug in patients with liver cirrhosis

Country Status (1)

Country Link
MD (1) MD4458C1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0827742A1 (en) * 1996-09-04 1998-03-11 Vrije Universiteit Brussel Use of histone deacetylase inhibitors for treating fribosis or cirrhosis
MD1780G2 (en) * 2001-02-02 2002-05-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method of treatment of patients with hepatic cirrhosis
DE102005025906A1 (en) * 2005-06-06 2006-12-07 Dorian Bevec Use of a guanylhydrazone compound in the manufacture of medicament for the treatment and/or prevention of e.g. acute and chronic hepatitis, liver cirrhosis, liver cell carcinoma, myocarditis, pharyngitis, pneumonia and pericarditis
DE102005059750A1 (en) * 2005-12-09 2007-06-14 Salama, Zoser Boulis, Dr. Use of tetraorganosilicon compound having cell proliferation inhibitory activity, e.g. as an immunstimulator to treat viral-, bacterial- and/or tumor diseases, anemia, arteriosclerosis, arthritis, asthma, autoimmune disease, and cirrhosis
FR2952826B1 (en) * 2009-11-20 2012-04-06 Lab Francais Du Fractionnement USE OF MULTIPURPOSE IMMUNOGLOBULINS FOR TREATING ALCOHOLIC OR METABOLIC HEPATIC CIRRHOSIS
MD4317C1 (en) * 2013-09-12 2015-08-31 Георге АНГЕЛИЧ Use of 3-(2,2,2-trimethylhydrazinium)propionate dihydrate for treating patients with advanced liver cirrhosis associated with heart failure

Also Published As

Publication number Publication date
MD4458C1 (en) 2017-08-31
MD4458B1 (en) 2017-01-31

Similar Documents

Publication Publication Date Title
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
TN2017000554A1 (en) Novel combination for use in the treatment of cancer
MX370792B (en) Methods and compositions for the treatment of cancer.
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
EA201790726A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
NZ710291A (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2018006226A (en) 5-hydroxytryptamine 1b receptor-stimulating agent for enhancing in vivo engraftment potential.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MD4763B1 (en) Pharmaceutical composition
PH12017500323A1 (en) P38 map kinase inhibiting indanyl urea compounds
MD20150017A2 (en) Use of Polybiolin drug in patients with liver cirrhosis
MX2016013979A (en) New administration routes of insulin, insulin analogs or derivatives of insulin.
MD4317B1 (en) Use of 3-(2,2,2-trimethylhydrazinium)propionate dihydrate for treating patients with advanced liver cirrhosis associated with heart failure
TR201716203A1 (en) New umeclidinium formulations.
MX2017005669A (en) Benzylhydroxyde derivatives, preparation thereof and therapeutic use thereof.
MD4316C1 (en) Use of 3-(2,2,2-trimethylhydrazinium)propionate dihydrate for treating portal gastropathies in patients with liver cirrhosis
PL414785A1 (en) 3-dodecylsulfanyl-butyric acid to be used as a medicine, preferably to prevent development of insulin immunity and the composition containing 3-dodecylsulfanyl-butyric acid as active substance
BR112017003900A2 (en) testosterone formulations and treatment methods with them
IN2014DE00822A (en)
IN2013MU03838A (en)
MX366763B (en) PHARMACEUTICAL COMPOSITIONS OF MONTELUKAST and LEVOCETIRIZINE.
UA91605U (en) Method for correcting disordered microcirculation in gastric mucosa of aged patients

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees